Witryna24 lut 2024 · NEW YORK, February 24, 2024 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced financial results for the fourth quarter and year ended December 31, 2024 … Witryna1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 332 2559811 Email: [email protected]
Immunic Therapeutics on Twitter: "🌾🍞 That is why testing is so ...
WitrynaSenior Medical Director bei Immunic Therapeutics München, Bayern, Deutschland. 391 Follower:innen 390 Kontakte. Mitglied werden und folgen Immunic Therapeutics. … WitrynaImmunic Therapeutics Biotechnologieforschung New York City, New York 3.525 Follower:innen Immunic is a biotechnology company developing small molecule … bambus angel
Immunic AG: Informationen und Neuigkeiten XING
WitrynaWeitere Startups in der Nähe von Immunic Therapeutics. SCAILEX. Startup 2024 Gräfelfing. SCAILEX. Intelligente Cloud-Plattform, die komplexe Prozesse der juristischen Sachbearbeitung maximal automatisiert und Ihr Business skaliert. ROCKITdigital. Startup 2013 Gräfelfing. ROCKITdigital. Witryna23 sie 2024 · Selective Oral Drugs in Immunology. Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and … Witryna20 paź 2024 · NEW YORK, October 20, 2024 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced the outcome of a pre-planned interim group-level data … ar rahman kaligrafi